Farallon Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.7K | Hold |
26,000
| – | – | ﹤0.01% | 133 |
|
|
2025
Q1 | $86.6K | Hold |
26,000
| – | – | ﹤0.01% | 131 |
|
|
2024
Q4 | $192K | Hold |
26,000
| – | – | ﹤0.01% | 124 |
|
|
2024
Q3 | $244K | Hold |
26,000
| – | – | ﹤0.01% | 123 |
|
|
2024
Q2 | $209K | Hold |
26,000
| – | – | ﹤0.01% | 129 |
|
|
2024
Q1 | $385K | Sell |
26,000
-536,000
| -95% | -$7.94M | ﹤0.01% | 122 |
|
|
2023
Q4 | $4.57M | Buy |
+562,000
| New | +$4.57M | 0.02% | 91 |
|
|
2022
Q3 | – | Sell |
-3,176,773
| Closed | -$35.1M | – | 315 |
|
|
2022
Q2 | $35.1M | Sell |
3,176,773
-2,998,584
| -49% | -$33.1M | 0.19% | 77 |
|
|
2022
Q1 | $103M | Buy |
6,175,357
+113,384
| +2% | +$1.89M | 0.5% | 49 |
|
|
2021
Q4 | $116M | Buy |
6,061,973
+721,979
| +14% | +$13.8M | 0.58% | 42 |
|
|
2021
Q3 | $132M | Buy |
5,339,994
+89,994
| +2% | +$2.22M | 0.61% | 45 |
|
|
2021
Q2 | $137M | Buy |
5,250,000
+500,000
| +11% | +$13M | 0.56% | 44 |
|
|
2021
Q1 | $150M | Sell |
4,750,000
-1,250,000
| -21% | -$39.6M | 0.75% | 38 |
|
|
2020
Q4 | $278M | Buy |
6,000,000
+45,000
| +0.8% | +$2.09M | 1.67% | 24 |
|
|
2020
Q3 | $196M | Sell |
5,955,000
-582,500
| -9% | -$19.2M | 1.36% | 27 |
|
|
2020
Q2 | $179M | Buy |
6,537,500
+787,500
| +14% | +$21.6M | 1.44% | 27 |
|
|
2020
Q1 | $172M | Sell |
5,750,000
-500,000
| -8% | -$15M | 1.48% | 24 |
|
|
2019
Q4 | $173M | Buy |
6,250,000
+225,000
| +4% | +$6.23M | 1.17% | 28 |
|
|
2019
Q3 | $110M | Buy |
6,025,000
+300,000
| +5% | +$5.46M | 0.83% | 29 |
|
|
2019
Q2 | $140M | Hold |
5,725,000
| – | – | 0.91% | 29 |
|
|
2019
Q1 | $54.4M | Hold |
5,725,000
| – | – | 0.41% | 48 |
|
|
2018
Q4 | $50.7M | Buy |
5,725,000
+1,000,000
| +21% | +$8.85M | 0.37% | 43 |
|
|
2018
Q3 | $53.2M | Buy |
4,725,000
+300,000
| +7% | +$3.37M | 0.31% | 48 |
|
|
2018
Q2 | $56.6M | Buy |
4,425,000
+275,000
| +7% | +$3.52M | 0.35% | 47 |
|
|
2018
Q1 | $70.1M | Buy |
4,150,000
+2,283,100
| +122% | +$38.6M | 0.49% | 41 |
|
|
2017
Q4 | $14.9M | Buy |
1,866,900
+1,016,900
| +120% | +$8.14M | 0.12% | 59 |
|
|
2017
Q3 | $6.59M | Buy |
+850,000
| New | +$6.59M | 0.06% | 75 |
|